Archive | SIRION Biotech GmbH

Page 2 of 6
50423Succeed with Sirion – LentiBOOST®
Succeed with Sirion – LentiBOOST® Learn More >
50314Succeed with Sirion – Cancer Immunotherapy
Succeed with Sirion – Cancer Immunotherapy Learn More >
50239Succeed with Sirion
Succeed with Sirion Learn More >
PerkinElmer agrees to acquire SIRION Biotech
PerkinElmer agrees to acquire SIRION Biotech Learn More >
SIRION Biotech scoops double GHP Biotechnology Awards for 2021
SIRION Biotech scoops double GHP Biotechnology Awards for 2021 Learn More >
49751SIRION Biotech Transient Adenovirus Development
SIRION Biotech Transient Adenovirus Development Learn More >
49434SIRION enhancers for viral transduction
SIRION enhancers for viral transduction Learn More >
SIRION Biotech to collaborate with Sanofi on improved AAV capsids
SIRION Biotech to collaborate with Sanofi on improved AAV capsids Learn More >
Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)
Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”) Learn More >
SIRION Biotech GmbH licensed its LentiBOOST™ transduction technology to Cellectis
SIRION Biotech GmbH licensed its LentiBOOST™ transduction technology to Cellectis Learn More >
48936SIRION adeno-associated virus (AAV) vector services
SIRION adeno-associated virus (AAV) vector services Learn More >
48867SIRION Biotech Lentiviral Services
SIRION Biotech Lentiviral Services Learn More >
Page 2 of 6